Clinical Trial Update: Long-term Safety & Performance of REVISYON SDS100 in Mild to Moderate Cataract: Extension Study (EB-CE-02)

View source ↗

Summary

This clinical trial update notes the extension study EB-CE-02 evaluating the long-term safety and performance of REVISYON SDS100 in mild to moderate age-related…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Cataract
• Cataract

Drugs mentioned

• REVISYON SDS100 (SDS100)

Snippet

Sponsor: Edinburgh Biosciences Ltd | Conditions: Age-related Cataract, Vision Loss | Status: ENROLLING_BY_INVITATION